Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Primary lung cancer remains the most common malignancy after non-melanocytic skin
cancer, and deaths from lung cancer exceed those from any other malignancy worldwide [1] …
cancer, and deaths from lung cancer exceed those from any other malignancy worldwide [1] …
Perspectives on the treatment of malignant pleural mesothelioma
Mesothelioma Most mesotheliomas originate in the pleura and are due to asbestos
exposure. The incidence is decreasing somewhat with asbestos remediation, but mortality …
exposure. The incidence is decreasing somewhat with asbestos remediation, but mortality …
Management of malignant pleural effusions. An official ATS/STS/STR clinical practice guideline
DJ Feller-Kopman, CB Reddy… - American journal of …, 2018 - atsjournals.org
Background: This Guideline, a collaborative effort from the American Thoracic Society,
Society of Thoracic Surgeons, and Society of Thoracic Radiology, aims to provide evidence …
Society of Thoracic Surgeons, and Society of Thoracic Radiology, aims to provide evidence …
Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
S Novello, F Barlesi, R Califano, T Cufer… - Annals of …, 2016 - annalsofoncology.org
Primary lung cancer remains the most common malignancy after non-melanocytic skin
cancer, and deaths from lung cancer exceed those from any other malignancy worldwide [1] …
cancer, and deaths from lung cancer exceed those from any other malignancy worldwide [1] …
Correction to:“Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up”
D Planchard, S Popat, K Kerr, S Novello… - Annals of …, 2019 - annalsofoncology.org
1. In KEYNOTE-189, patients with metastatic non-squamous NSCLC, PS 0-1, without
sensitising EGFR or ALK mutations, were randomised to receive pemetrexed and a platinum …
sensitising EGFR or ALK mutations, were randomised to receive pemetrexed and a platinum …
ERS/EACTS statement on the management of malignant pleural effusions
AC Bibby, P Dorn, I Psallidas, JM Porcel… - European journal of …, 2019 - academic.oup.com
Malignant pleural effusions (MPE) are a common pathology, treated by respiratory
physicians and thoracic surgeons alike. In recent years, several well-designed randomized …
physicians and thoracic surgeons alike. In recent years, several well-designed randomized …
Pleural disease
D Feller-Kopman, R Light - New england journal of medicine, 2018 - Mass Medical Soc
Pleural Disease This review discusses the substantial advances that have been made in our
understanding of pleural biology and related pathophysiology, as well as in the …
understanding of pleural biology and related pathophysiology, as well as in the …
Reporting of patient-reported outcomes in randomized trials: the CONSORT PRO extension
The CONSORT (Consolidated Standards of Reporting Trials) Statement aims to improve the
reporting of randomized controlled trials (RCTs); however, it lacks guidance on the reporting …
reporting of randomized controlled trials (RCTs); however, it lacks guidance on the reporting …
[HTML][HTML] Malignant pleural mesothelioma: an update on investigation, diagnosis and treatment
AC Bibby, S Tsim, N Kanellakis, H Ball… - European …, 2016 - Eur Respiratory Soc
Malignant pleural mesothelioma is an aggressive malignancy of the pleural surface,
predominantly caused by prior asbestos exposure. There is a global epidemic of malignant …
predominantly caused by prior asbestos exposure. There is a global epidemic of malignant …
Effect of an indwelling pleural catheter vs talc pleurodesis on hospitalization days in patients with malignant pleural effusion: the AMPLE randomized clinical trial
Importance Indwelling pleural catheter and talc pleurodesis are established treatments for
malignant pleural effusions among patients with poor prognosis. Objective To determine …
malignant pleural effusions among patients with poor prognosis. Objective To determine …